Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 27;143(17):1729-1731.
doi: 10.1161/CIRCULATIONAHA.120.053168. Epub 2021 Apr 26.

Serial Versus Single Cardiovascular Screening of Adolescent Athletes

Affiliations

Serial Versus Single Cardiovascular Screening of Adolescent Athletes

Patrizio Sarto et al. Circulation. .
No abstract available

Keywords: adolescent; athletes; cardiovascular diseases.

PubMed Disclaimer

Figures

Figure.
Figure.
Diagnoses of cardiovascular diseases at preparticipation cardiovascular screening. A, Pie chart shows the distribution of the 63 diagnoses of cardiovascular diseases at risk of sudden cardiac death (SCD). B, Pie chart shows the distribution of the 266 diagnoses of cardiac conditions not associated with SCD. C, Bar graph shows the distribution of diagnoses of cardiovascular diseases at risk of SCD according to the athlete’s age. Athletes with inherited cardiomyopathies and isolated nonischemic left ventricular scar with ventricular arrhythmias were significantly older at the time of diagnosis by preparticipation screening than those with congenital heart diseases and long QT syndrome. D, Bar graph shows the distribution of diagnoses of cardiovascular diseases at risk of SCD according to the preparticipation cardiovascular evaluations. Sixty-five percent of diagnoses of a cardiovascular disease at risk of SCD were made on repeat screening. More frequently identified by serial evaluations were inherited cardiomyopathies (64%) with a late phenotypic expression and acquired nonischemic left ventricular scar with ventricular arrhythmias (83%) that newly developed over follow-up. LV indicates left ventricular.

Similar articles

Cited by

References

    1. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998; 339:364–369. doi: 10.1056/NEJM199808063390602 - PubMed
    1. Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, Panhuyzen-Goedkoop N, Deligiannis A, Solberg E, Dugmore D, et al. ; Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: consensus statement of the study group of sport cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial diseases of the European Society of Cardiology. Eur Heart J. 2005; 26:516–524. doi: 10.1093/eurheartj/ehi108 - PubMed
    1. Zorzi A, Vessella T, De Lazzari M, Cipriani A, Menegon V, Sarto G, Spagnol R, Merlo L, Pegoraro C, Marra MP, et al. . Screening young athletes for diseases at risk of sudden cardiac death: role of stress testing for ventricular arrhythmias. Eur J Prev Cardiol. 2020; 27:311–320. doi: 10.1177/2047487319890973 - PMC - PubMed
    1. Zorzi A, Perazzolo Marra M, Rigato I, De Lazzari M, Susana A, Niero A, Pilichou K, Migliore F, Rizzo S, Giorgi B, et al. . Nonischemic left ventricular scar as a substrate of life-threatening ventricular arrhythmias and sudden cardiac death in competitive athletes. Circ Arrhythm Electrophysiol. 2016; 9:e004229. doi: 10.1161/CIRCEP.116.004229 - PMC - PubMed
    1. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006; 296:1593–1601. doi: 10.1001/jama.296.13.1593 - PubMed